Stay updated with breaking news from Caredx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CareDx, Inc (NASDAQ:CDNA – Get Rating) Director Michael Goldberg sold 500 shares of the firm’s stock in a transaction that occurred on Monday, April 11th. The stock was sold at an average price of $36.01, for a total transaction of $18,005.00. Following the completion of the sale, the director now owns 62,267 shares in the […]
Russell Investments Group Ltd. lowered its position in shares of CareDx, Inc (NASDAQ:CDNA – Get Rating) by 63.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,706 shares of the company’s stock after selling 38,181 shares during the period. Russell Investments […]
Symposium, “Improved Precision with a Multimodality Approach,” Reviews Innovative Solutions for a More Holistic View of Allograft Health...
SOUTH SAN FRANCISCO, Calif., March 30, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated
SOUTH SAN FRANCISCO, Calif., March 30, 2022 -- CareDx, Inc. – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated,... | March 30, 2022